Terry-Ann Burrell
Director of Finance/CFO bei BEAM THERAPEUTICS INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Derzeit ist Terry-Ann Burrell Chief Financial Officer & Treasurer von Beam Therapeutics, Inc. Frau Burrell ist auch im Vorstand von Recursion Pharmaceuticals, Inc. In ihrer früheren Karriere hatte sie die Position eines Managing Director bei JPMorgan Securities LLC inne. Frau Burrell erhielt einen Bachelor-Abschluss von der Harvard University und einen MBA von der Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0,09% | 01.04.2024 | 70 137 ( 0,09% ) | 2 Mio $ | 31.03.2024 |
| 01.04.2024 | 56 314 ( 0,03% ) | 561 451 $ | 31.03.2024 |
Aktive Positionen von Terry-Ann Burrell
| Unternehmen | Position | Beginn |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 01.08.2019 |
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 01.04.2020 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Director/Board Member | 16.01.2024 |
Ehemalige bekannte Positionen von Terry-Ann Burrell
| Unternehmen | Position | Ende |
|---|---|---|
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01.08.2019 |
Ausbildung von Terry-Ann Burrell
| Harvard University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
